A roadmap for a patient-centred approach to Pompe disease management
Implementing gene therapy for Pompe disease requires a coordinated multidisciplinary effort to overcome gaps in knowledge, infrastructure, and patient management.
Authors
- P. Lafôret
- Andreas Thalmeier
- Cristina Domínguez-González
- Paul Gissen
- Anna Kostera-Pruszczyk
- Andreas Hahn
- John Vissing
- Benedikt Schoser
Institutions
- University of Copenhagen (DK)
- Justus-Liebig-Universität Gießen (DE)
- Medical University of Warsaw (PL)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- LMU Klinikum (DE)
- National Institute for Health and Care Research (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hôpital Raymond-Poincaré (FR)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1007/s00415-026-13687-3
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- Sanofi
- Biogen
- Alexion Pharmaceuticals
- CSL Behring
- Batten Disease Family Association
- Amicus Therapeutics
- Astellas Pharma
- Novo Nordisk Fonden
- Medical Research Council
- Instituto de Salud Carlos III
- Janssen Pharmaceuticals
- UCB Pharma